-
1
-
-
85047698527
-
The rising tide of ESRF from diabetic nephropathy type II and epidemiological analysis
-
Lippert J, Rit E, Schwarzbeck A, Schneider P. The rising tide of ESRF from diabetic nephropathy type II and epidemiological analysis. Nephrol Dial Transplant 1995; 10: 462-7.
-
(1995)
Nephrol Dial Transplant
, vol.10
, pp. 462-467
-
-
Lippert, J.1
Rit, E.2
Schwarzbeck, A.3
Schneider, P.4
-
2
-
-
0029995388
-
Benefits of long term antihypertensive treatment on the prognosis in diabetic nephropathy
-
Parving H, Jacobsen P, Rossing K, Smidth UM, Hommel E, Rossing P. Benefits of long term antihypertensive treatment on the prognosis in diabetic nephropathy. Kidney Int 1986; 49: 1779-82.
-
(1986)
Kidney Int
, vol.49
, pp. 1779-1782
-
-
Parving, H.1
Jacobsen, P.2
Rossing, K.3
Smidth, U.M.4
Hommel, E.5
Rossing, P.6
-
3
-
-
0027517659
-
The effect of angiotensin converting enzyme inhibitors on diabetic nephropathy
-
Lewis EL, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin converting enzyme inhibitors on diabetic nephropathy. N Eng J Med 1983; 329: 1456-62.
-
(1983)
N Eng J Med
, vol.329
, pp. 1456-1462
-
-
Lewis, E.L.1
Hunsicker, L.G.2
Bain, R.P.3
Rohde, R.D.4
-
4
-
-
0031779392
-
A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function
-
Kasiske BL, Lakatura JD, Ma JZ, Lousis TA. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998; 31: 954-61.
-
(1998)
Am J Kidney Dis
, vol.31
, pp. 954-961
-
-
Kasiske, B.L.1
Lakatura, J.D.2
Ma, J.Z.3
Lousis, T.A.4
-
5
-
-
0006535220
-
Hypercholesterolemia - A determinant of renal function loss and deaths in IDDM and nephropathy
-
Krolewski AS, Warram JH, Christilieb AR. Hypercholesterolemia - A determinant of renal function loss and deaths in IDDM and nephropathy. Kidney Int 1994; 45: S125-31.
-
(1994)
Kidney Int
, vol.45
-
-
Krolewski, A.S.1
Warram, J.H.2
Christilieb, A.R.3
-
6
-
-
0035922444
-
The effect of irbesartan on the d3velopment of diabetic nephropathy in patients with type 2 diabetes
-
Parving H, Lehnert H, Brochner-Mortansen J, Gomis R, Anderson S, Arner P. The effect of irbesartan on the d3velopment of diabetic nephropathy in patients with type 2 diabetes. N Eng J Med 2001; 345:870-8.
-
(2001)
N Eng J Med
, vol.345
, pp. 870-878
-
-
Parving, H.1
Lehnert, H.2
Brochner-Mortansen, J.3
Gomis, R.4
Anderson, S.5
Arner, P.6
-
7
-
-
0035922435
-
Prevention of end-stage renal disease due to type 2 diabetes
-
Hostetter TH. Prevention of end-stage renal disease due to type 2 diabetes. N Eng J Med 2001; 345: 910-1.
-
(2001)
N Eng J Med
, vol.345
, pp. 910-911
-
-
Hostetter, T.H.1
-
8
-
-
0003072603
-
Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor
-
Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6: 24-7.
-
(1969)
Ann Clin Biochem
, vol.6
, pp. 24-27
-
-
Trinder, P.1
-
10
-
-
78651190784
-
Automated and manual direct methods for the determination of blood urea
-
Marsh WH, Fingerhut B, Miller H. Automated and manual direct methods for the determination of blood urea. Clin Chem 1965; 11: 624-7.
-
(1965)
Clin Chem
, vol.11
, pp. 624-627
-
-
Marsh, W.H.1
Fingerhut, B.2
Miller, H.3
|